FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18611411000001104: Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Apr 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
63847301000001112 Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
78130101000001118 Seretide 500 Accuhaler (DE Pharmaceuticals) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) Is a Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) Is a Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler false Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) Has active ingredient Salmeterol true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) Has active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) Has manufactured dose form Breath activated powder inhaler false Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) Has specific active ingredient Salmeterol xinafoate true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) Has specific active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) Has dispensed dose form Conventional release powder for inhalation true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) Is a Seretide Accuhaler true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP not recommended to prescribe - patient training required false Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) Has basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) Is a Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) 60 dose Has AMP True Seretide 500 Accuhaler (Doncaster Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start